1. Silencing of BAG3 promotes the sensitivity of ovarian cancer cells to cisplatin via inhibition of autophagy
   Shuang Qiu et al, 2017 CrossRef
2. null
   Santanu Maji et al, 2017 CrossRef
3. Mcl-1 targeting could be an intriguing perspective to cure cancer
   Anna De Blasio et al, 2018, J Cell Physiol CrossRef
4. Cytoprotective effect of 2-carbomethoxy-2,3-epoxy-3-prenyl-1,4-naphthoquinone (CMEP-NQ) is mediated by the inhibition of BAK-dependent mitochondrial apoptosis pathway
   Do Youn Jun et al, 2018, PLoS ONE CrossRef
5. miR-153-3p regulates progression of ovarian carcinoma in vitro and in vivo by targeting MCL1 gene.
   Cui Li et al, 2019, J Cell Biochem CrossRef
6. Functional analysis of deubiquitylating enzymes in tumorigenesis and development
   Ji Cheng et al, 2019, Biochimica et Biophysica Acta (BBA) - Reviews on Cancer CrossRef
7. The deubiquitinating enzyme OTUD1 antagonizes BH3-mimetic inhibitor induced cell death through regulating the stability of the MCL1 protein
   Lanqin Wu et al, 2019, Cancer Cell Int CrossRef
8. Geraniin suppresses ovarian cancer growth through inhibition of NF-κB activation and downregulation of Mcl-1 expression
   Xue Wang et al, 2017, J Biochem Mol Toxicol CrossRef
9. MCL1 regulates cell death, tumor growth and chemosensitivity to sabutoclax in ovarian adenocarcinoma
   Cui Li et al, 2019, Cell Tissue Res CrossRef
10. A BAG's life: Every connection matters in cancer
    Elena Mariotto et al, 2020, Pharmacology & Therapeutics CrossRef
11. BAG3 promotes chondrosarcoma progression by upregulating the expression of β-catenin
    Huijuan Shi et al, 2018, Mol Med Report CrossRef
12. Downregulation of BAG3 attenuates cisplatin resistance by inhibiting autophagy in human epithelial ovarian cancer cells
    Shuang Qiu et al, 2019, Oncol Lett CrossRef
13. Mechanisms of Taxane Resistance
    Sara M. Maloney et al, 2020, Cancers CrossRef
14. Knockdown of BAG3 synergizes with olaparib to kill ovarian cancer cells via repressing autophagy
    Kexin Wang et al, 2020, J Investig Med CrossRef
15. The role of post-translational modifications in the regulation of MCL1
    Shujing Li et al, 2021, Cellular Signalling CrossRef
16. Multifunctional Role of Astrocyte Elevated Gene-1 (AEG-1) in Cancer: Focus on Drug Resistance
    Debashri Manna et al, 2021, Cancers CrossRef
17. Targeting MCL-1 in cancer: current status and perspectives
    Haolan Wang et al, 2021, J Hematol Oncol CrossRef
18. The role of BAG3 in health and disease: A "Magic BAG of Tricks".
    Heng Lin et al, 2021, J Cell Biochem CrossRef
19. An emerging role for BAG3 in gynaecological malignancies
    Margot De Marco et al, 2021, Br J Cancer CrossRef
20. USP9X promotes apoptosis in cholangiocarcinoma by modulation expression of KIF1Bβ via deubiquitinating EGLN3
    Weiqian Chen et al, 2021, J Biomed Sci CrossRef
21. Dual inhibition of FGFR4 and BCL-xL inhibits multi-resistant ovarian cancer with BCL2L1 gain
    Ting Guo et al, 2021, Aging CrossRef
22. Integrated profiling of human pancreatic cancer organoids reveals chromatin accessibility features associated with drug sensitivity
    Xiaohan Shi et al, 2022, Nat Commun CrossRef
23. Unraveling the mystery: How bad is BAG3 in hematological malignancies?
    Qinghan Liu et al, 2022, Biochimica et Biophysica Acta (BBA) - Reviews on Cancer CrossRef
24. Genomic and Epigenomic Characterization of Tumor Organoid Models
    Chehyun Nam et al, 2022, Cancers CrossRef
25. Bioinformatics analysis of the clinicopathological and prognostic significance of BAG3 mRNA in gynecological cancers
    Zi-mo Wang et al, 2023, Journal of Obstetrics and Gynaecology CrossRef
26. Bcl-2 family inhibitors sensitize human cancer models to therapy
    Elisabetta Valentini et al, 2023, Cell Death Dis CrossRef
27. Cellular functions, molecular signalings and therapeutic applications: Translational potential of deubiquitylating enzyme USP9X as a drug target in cancer treatment
    Hongli Gao et al, 2024, Biochimica et Biophysica Acta (BBA) - Reviews on Cancer CrossRef